Epidemiology of Hypertension in CKD

Advances in Chronic Kidney Disease - Tập 22 - Trang 88-95 - 2015
Bruce Horowitz1, Dana Miskulin1, Philip Zager1
1University of New Mexico, Albuquerque, NM; Tufts University, Boston, MA; and Dialysis Clinic, Inc, Nashville, TN

Tài liệu tham khảo

James, 2014, 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8), JAMA, 311, 507, 10.1001/jama.2013.284427

Levey, 2006, Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate, Ann Intern Med, 145, 247, 10.7326/0003-4819-145-4-200608150-00004

Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006

Yoon, 2012, Hypertension among adults in the United States, 2009-2010, NCHS Data Brief, 107, 1

Coresh, 2007, Prevalence of chronic kidney disease in the United States, JAMA, 298, 2038, 10.1001/jama.298.17.2038

Stevens, 2010, Comparative performance of the CKD Epidemiology Collaboration (CKD-EPI) and the Modification of Diet in Renal Disease (MDRD) Study equations for estimating GFR levels above 60 mL/min/1.73 m2, Am J Kidney Dis, 56, 486, 10.1053/j.ajkd.2010.03.026

Buckalew, 1996, Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group, Am J Kidney Dis, 28, 811, 10.1016/S0272-6386(96)90380-7

Whaley-Connell, 2008, CKD in the United States: kidney early evaluation program (KEEP) and national health and nutrition examination survey (NHANES) 1999-2004, Am J Kidney Dis, 51, S13, 10.1053/j.ajkd.2007.12.016

Hsu, 2005, Apolipoprotein E and progression of chronic kidney disease, JAMA, 293, 2892, 10.1001/jama.293.23.2892

Ghattas, 2013, Apolipoprotein CIII3238C/G gene polymorphism influences oxidized low-density lipoprotein with a risk of essential hypertension, J Biochem Pharmacol Res, 1, 143

Renal Data System, 2013

Muntner, 2010, Hypertension awareness, treatment, and control in adults with CKD: results from the Chronic Renal Insufficiency Cohort (CRIC) Study, Am J Kidney Dis, 55, 441, 10.1053/j.ajkd.2009.09.014

Jurkovitz, 2008, The Kidney Early Evaluation Program (KEEP): program design and demographic characteristics of the population, Am J Kidney Dis, 51, S3, 10.1053/j.ajkd.2007.12.022

Kalaitzidis, 2009, Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP), Am J Kidney Dis, 53, S22, 10.1053/j.ajkd.2008.11.028

Rao, 2008, Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES), 1999-2004, Am J Kidney Dis, 51, S30, 10.1053/j.ajkd.2007.12.012

Zheng, 2013, Prevalence, awareness, treatment, and control of hypertension in the non-dialysis chronic kidney disease patients, Chin Med J (Engl), 126, 2276

Singh, 2013, Epidemiology and risk factors of chronic kidney disease in India—results from the SEEK (Screening and Early Evaluation of Kidney Disease) study, BMC Nephrol, 14, 114, 10.1186/1471-2369-14-114

Obrador, 2010, Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) Mexico and comparison with KEEP US, Kidney Int Suppl, 116, S2, 10.1038/ki.2009.540

Agarwal, 2005, Correlates of systolic hypertension in patients with chronic kidney disease, Hypertension, 46, 514, 10.1161/01.HYP.0000178102.85718.66

Ridao, 2001, Prevalence of hypertension in renal disease, Nephrol Dial Transplant, 16, 70, 10.1093/ndt/16.suppl_1.70

Inker, 2011, Estimated GFR, albuminuria, and complications of chronic kidney disease, J Am Soc Nephrol, 22, 2322, 10.1681/ASN.2010111181

Peralta, 2005, Control of hypertension in adults with chronic kidney disease in the United States, Hypertension, 45, 1119, 10.1161/01.HYP.0000164577.81087.70

Renal Data System, 2012

Peralta, 2006, Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease, J Am Soc Nephrol, 17, 2892, 10.1681/ASN.2005101122

Ferdinand, 2015, Hypertension in minority populations: new guidelines and emerging concepts, Adv Chronic Kidney Dis, 22, 145, 10.1053/j.ackd.2014.08.004

Ferguson, 1988, A familial risk of chronic renal failure among blacks on dialysis?, J Clin Epidemiol, 41, 1189, 10.1016/0895-4356(88)90023-6

Lipkowitz, 2013, Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans, Kidney Int, 83, 114, 10.1038/ki.2012.263

Kao, 2008, MYH9 is associated with nondiabetic end-stage renal disease in African Americans, Nat Genet, 40, 1185, 10.1038/ng.232

Kopp, 2008, MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis, Nat Genet, 40, 1175, 10.1038/ng.226

Nelson, 2010, Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15, Hum Mol Genet, 19, 1805, 10.1093/hmg/ddq039

Madhavan, 2011, APOL1 localization in normal kidney and nondiabetic kidney disease, J Am Soc Nephrol, 22, 2119, 10.1681/ASN.2011010069

Genovese, 2010, Association of trypanolytic ApoL1 variants with kidney disease in African Americans, Science, 329, 841, 10.1126/science.1193032

Tzur, 2012, APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease, Nephrol Dial Transplant, 27, 1498, 10.1093/ndt/gfr796

Freedman, 2008, Hypertension-associated kidney disease: perhaps no more, J Am Soc Nephrol, 19, 2047, 10.1681/ASN.2008060621

Yamamoto, 1997, The effect of sodium restriction and weight reduction on blood pressure of patients with hypertension and chronic renal disease, J Ren Nutr, 7, 25, 10.1016/S1051-2276(97)90005-4

Calhoun, 2008, Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research, Hypertension, 51, 1403, 10.1161/HYPERTENSIONAHA.108.189141

Persell, 2011, Prevalence of resistant hypertension in the United States, 2003-2008, Hypertension, 57, 1076, 10.1161/HYPERTENSIONAHA.111.170308

De, 2013, Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients, J Am Coll Cardiol, 61, 2461, 10.1016/j.jacc.2012.12.061

Egan, 2010, US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008, JAMA, 303, 2043, 10.1001/jama.2010.650

Sarafidis, 2008, Hypertension awareness, treatment, and control in chronic kidney disease, Am J Med, 121, 332, 10.1016/j.amjmed.2007.11.025

Coresh, 2001, Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994), Arch Intern Med, 161, 1207, 10.1001/archinte.161.9.1207

Fischer, 2011, CKD in Hispanics: baseline characteristics from the CRIC (Chronic Renal Insufficiency Cohort) and Hispanic-CRIC studies, Am J Kidney Dis, 58, 214, 10.1053/j.ajkd.2011.05.010

Duru, 2008, Race and sex differences in hypertension control in CKD: results from the Kidney Early Evaluation Program (KEEP), Am J Kidney Dis, 51, 192, 10.1053/j.ajkd.2007.09.023

Kramer, 2004, Racial/ethnic differences in hypertension and hypertension treatment and control in the multi-ethnic study of atherosclerosis (MESA), Am J Hypertens, 17, 963, 10.1016/j.amjhyper.2004.06.001

Hebert, 1997, Effects of blood pressure control on progressive renal disease in blacks and whites. Modification of Diet in Renal Disease Study Group, Hypertension, 30, 428, 10.1161/01.HYP.30.3.428

Altun, 2012, Prevalence, awareness, treatment and control of hypertension in adults with chronic kidney disease in Turkey: results from the CREDIT study, Kidney Blood Press Res, 36, 36, 10.1159/000339025

Renal Data System, 2010

Gu, 2012, Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health and Nutrition Examination Survey, 2001 to 2010, Circulation, 126, 2105, 10.1161/CIRCULATIONAHA.112.096156

Lazarus, 1974, Hypertension in chronic renal failure. Treatment with hemodialysis and nephrectomy, Arch Intern Med, 133, 1059, 10.1001/archinte.1974.00320180177015

Jacobsen, 1999, Progression of diabetic nephropathy in normotensive type 1 diabetic patients, Kidney Int Suppl, 71, S101, 10.1046/j.1523-1755.1999.07125.x

Klahr, 1994, The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group, N Engl J Med, 330, 877, 10.1056/NEJM199403313301301

Fogo, 1997, Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) trial. AASK Pilot Study Investigators, Kidney Int, 51, 244, 10.1038/ki.1997.29

Klag, 1997, End-stage renal disease in African-American and white men. 16-year MRFIT findings, JAMA, 277, 1293, 10.1001/jama.1997.03540400043029

Klag, 1996, Blood pressure and end-stage renal disease in men, N Engl J Med, 334, 13, 10.1056/NEJM199601043340103

Flack, 1993, Ethnicity and renal disease: lessons from the multiple risk factor intervention trial and the treatment of mild hypertension study, Am J Kidney Dis, 21, 31, 10.1016/S0272-6386(12)80859-6

Whelton, 1989, Hypertension as a risk factor for renal disease. Review of clinical and epidemiological evidence, Hypertension, 13, I19, 10.1161/01.HYP.13.5_Suppl.I19

Lewis, 1999, Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group, Am J Kidney Dis, 34, 809, 10.1016/S0272-6386(99)70036-3

Jafar, 2003, Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis, Ann Intern Med, 139, 244, 10.7326/0003-4819-139-4-200308190-00006

Pohl, 2005, Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations, J Am Soc Nephrol, 16, 3027, 10.1681/ASN.2004110919

Wright, 2002, Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial, JAMA, 288, 2421, 10.1001/jama.288.19.2421

Hsu, 2003, Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States, J Am Soc Nephrol, 14, 2902, 10.1097/01.ASN.0000091586.46532.B4

Kannel, 1969, Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study, Ann Intern Med, 71, 89, 10.7326/0003-4819-71-1-89

Lewington, 2002, Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, 360, 1903, 10.1016/S0140-6736(02)11911-8

Wolf, 1991, Probability of stroke: a risk profile from the Framingham Study, Stroke, 22, 312, 10.1161/01.STR.22.3.312

Chobanian, 2003, Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure, Hypertension, 42, 1206, 10.1161/01.HYP.0000107251.49515.c2

Kovesdy, 2014, Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease, JAMA Intern Med, 174, 1442, 10.1001/jamainternmed.2014.3279

Sim, 2014, Impact of Achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population, J Am Coll Cardiol, 64, 588, 10.1016/j.jacc.2014.04.065

Agarwal, 2003, Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States, Am J Med, 115, 291, 10.1016/S0002-9343(03)00366-8

Heerspink, 2009, Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials, Lancet, 373, 1009, 10.1016/S0140-6736(09)60212-9

Rohrscheib, 2008, Age-related blood pressure patterns and blood pressure variability among hemodialysis patients, Clin J Am Soc Nephrol, 3, 1407, 10.2215/CJN.00110108

Shafi, 2014, Predialysis systolic BP variability and outcomes in hemodialysis patients, J Am Soc Nephrol, 25, 799, 10.1681/ASN.2013060667

St Peter, 2013, Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months, BMC Nephrol, 14, 249, 10.1186/1471-2369-14-249

Agarwal, 2009, Meta-analysis-not proof but call for action, Hypertension, 54, e7, 10.1161/HYPERTENSIONAHA.109.133124

Davenport, 2008, Achieving blood pressure targets during dialysis improves control but increases intradialytic hypotension, Kidney Int, 73, 759, 10.1038/sj.ki.5002745

Port, 1999, Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients, Am J Kidney Dis, 33, 507, 10.1016/S0272-6386(99)70188-5

Tentori, 2013, Association of dialysate bicarbonate concentration with mortality in the Dialysis Outcomes and Practice Patterns Study (DOPPS), Am J Kidney Dis, 62, 738, 10.1053/j.ajkd.2013.03.035

Zager, 1998, “U” curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc, Kidney Int, 54, 561, 10.1046/j.1523-1755.1998.00005.x

Blumberg, 1967, Extracellular volume in patients with chronic renal disease treated for hypertension by sodium restriction, Lancet, 2, 69, 10.1016/S0140-6736(67)92061-2

Converse, 1992, Sympathetic overactivity in patients with chronic renal failure, N Engl J Med, 327, 1912, 10.1056/NEJM199212313272704

Dorhout Mees, 1999, Hypertension in haemodialysis patients: who cares?, Nephrol Dial Transplant, 14, 28, 10.1093/ndt/14.1.28

Fagugli, 2001, Short daily hemodialysis: blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients, Am J Kidney Dis, 38, 371, 10.1053/ajkd.2001.26103

Katzarski, 1999, Fluid state and blood pressure control in patients treated with long and short haemodialysis, Nephrol Dial Transplant, 14, 369, 10.1093/ndt/14.2.369

Lins, 1997, Importance of volume factors in dialysis related hypertension, Clin Nephrol, 48, 29

Luik, 2001, The influence of increasing dialysis treatment time and reducing dry weight on blood pressure control in hemodialysis patients: a prospective study, Am J Nephrol, 21, 471, 10.1159/000046651

Sanders, 2007, Assessment and treatment of hypertension in dialysis: the case for salt restriction, Semin Dial, 20, 408, 10.1111/j.1525-139X.2007.00316.x

Scribner, 1990, A personalized history of chronic hemodialysis, Am J Kidney Dis, 16, 511, 10.1016/S0272-6386(12)81034-1

Vertes, 1969, Hypertension in end-stage renal disease, N Engl J Med, 280, 978, 10.1056/NEJM196905012801802

Wilson, 2004, Role of sodium and volume in the pathogenesis of hypertension in hemodialysis, Semin Dial, 17, 260, 10.1111/j.0894-0959.2004.17323.x

Agarwal, 2009, Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial, Hypertension, 53, 500, 10.1161/HYPERTENSIONAHA.108.125674

Fagugli, 2003, Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients, Nephrol Dial Transplant, 18, 2332, 10.1093/ndt/gfg371

Krautzig, 1998, Dietary salt restriction and reduction of dialysate sodium to control hypertension in maintenance haemodialysis patients, Nephrol Dial Transplant, 13, 552, 10.1093/ndt/13.3.552

Ozkahya, 2002, Impact of volume control on left ventricular hypertrophy in dialysis patients, J Nephrol, 15, 655

Toz, 2007, Improvement in “uremic” cardiomyopathy by persistent ultrafiltration, Hemodial Int, 11, 46, 10.1111/j.1542-4758.2007.00153.x

Gul, 2014, Design of the blood pressure goals in dialysis pilot study, Am J Med Sci, 347, 125, 10.1097/MAJ.0b013e31827daee5

Agarwal, 2009, Home and ambulatory blood pressure monitoring in chronic kidney disease, Curr Opin Nephrol Hypertens, 18, 507, 10.1097/MNH.0b013e3283319b9d

Buoncristiani, 1988, Daily dialysis: long-term clinical metabolic results, Kidney Int Suppl, 24, S137

Chan, 2002, Regression of left ventricular hypertrophy after conversion to nocturnal hemodialysis, Kidney Int, 61, 2235, 10.1046/j.1523-1755.2002.00362.x

Chan, 2003, Short-term blood pressure, noradrenergic, and vascular effects of nocturnal home hemodialysis, Hypertension, 42, 925, 10.1161/01.HYP.0000097605.35343.64

Chertow, 2010, In-center hemodialysis six times per week versus three times per week, N Engl J Med, 363, 2287, 10.1056/NEJMoa1001593

Nesrallah, 2003, Volume control and blood pressure management in patients undergoing quotidian hemodialysis, Am J Kidney Dis, 42, 13, 10.1016/S0272-6386(03)00532-8

Rocco, 2011, The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial, Kidney Int, 80, 1080, 10.1038/ki.2011.213

Ting, 2003, Long-term study of high-comorbidity ESRD patients converted from conventional to short daily hemodialysis, Am J Kidney Dis, 42, 1020, 10.1016/j.ajkd.2003.07.020

Zilch, 2007, Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis, J Hypertens, 25, 1285, 10.1097/HJH.0b013e3280f9df85

Thông tin
Thông tin xuất bản

Advances in Chronic Kidney Disease

Tập 22

88-95

Thông tin tác giả